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Abstract:  
Thousands of people are infected with HIV/AIDS in Nepal and most of them are adults of working age. 
Therefore, HIV/AIDS is a big burden in Nepal. This review was conducted to find the existing knowledge gap 
about the economic burden of HIV/AIDS at the household level in Nepal, the extent of economic burden 
exerted by the disease, and to provide policy recommendations. It is concluded that there was a considerable 
knowledge gap about the issue, and the economic burden exerted by HIV/AIDS was big enough to push the 
affected households into poverty. It is suggested that more studies need to be conducted to fill the knowledge 
gap. Similarly, Government of Nepal and other organisations working in the field of HIV/AIDS need to 
provide economic supports (e.g.- support for travel costs) to the HIV positive people and need to increase the 
awareness level among general population for reducing stigma and discrimination, and reducing economic 
burden on them. 
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Introduction 
Economic Burden of HIV/AIDS 
Human Immunodeficiency Virus/Acquired Immunodeficiency 
Syndrome (HIV/AIDS) has health, economic and social 
consequences. HIV/AIDS causes health consequences 
resulting to the morbidity and mortality of infected people 
[1,2]. People with advanced HIV status are vulnerable to 
infections and malignancies, due to their poor immune system, 
called ‘opportunistic infections’. Many of the opportunistic 
infections occur during the advanced condition of HIV and can 
be fatal [3]. Increased adult morbidity and mortality due to 
HIV/AIDS are likely to have important consequences for 
households, communities and health systems [4]. The death of 
a HIV positive individual results in a permanent loss of 
income from less labour on the farm, lower remittances from 
jobs, costs associated with the funeral and mourning, and a 
possible removal of children from school in order to save on 
educational expenses and to increase household labour and 
income, resulting in a severe loss of future earning potential 
for the family [5]. Therefore, the health consequences of 
HIV/AIDS have an economic impact on the household.  
The HIV/AIDS-affected households need to pay a substantial 
amount of money for the care and treatment of their ill family 
members [6]. The disease affects the earning capacity of the 
person and other members of the households too. The HIV 
positive person may be very weak and may be absent from 
work or may lose their job due to the illness [7]. The working 
time of household members may be shifted from productive 
activities to the care of the sick family members, and thus 
household income declines further [8]. Thus, the economic 
consequences can be divided into- direct costs, productivity 
costs and other hidden costs (e.g. – loss of income).  
 
 
Figure 1. HIV/AIDS and its possible consequences 
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HIV/AIDS exerts social impacts and consequences too. 
HIV/AIDS is perhaps the most stigmatized disease in the 
world [9]. The disease is more prevalent in female sex 
workers, the clients of sex workers, injecting drug users and 
men who have sex with men (MSM) and it is often seen as a 
disease directly linked with personal behaviour. Therefore, 
people infected with HIV/AIDS face stigma and 
discrimination [10]. Stigma and discrimination in HIV/AIDS 
may result in either not seeking treatment [11] or seeking 
treatment far from the home where the patient is not known by 
the health care professionals and others [12]. This behaviour 
also has economic consequences because not seeking 
treatment means premature mortality and seeking treatment far 
from home means increased costs for the HIV-affected 
household. People living with HIV/AIDS (PLHA) might lose 
jobs due to stigma and discrimination from employers if 
known to them [13,14]. Rejection, isolation, less support from 
family, relatives, neighbours, friends, and community are also 
another consequence of the stigma and discrimination related 
to HIV/AIDS [13, 15]. Therefore, these social consequences 
also have an economic impact on the household. 
Households use a range of strategies to cope with the burden 
of illness (for both treatment costs and productivity losses) 
[16]. The immediate coping method of illness for those 
households who have cash or savings is to use the available 
cash and mobilise savings [17, 18]. Another frequently used 
strategy for those households who do not have cash or savings 
at all or have an insufficient amount is borrowing from family 
and friends or taking loan from money lenders, or sale of 
assets [18]. The effect of loans on households can be severe. 
Some studies show that households remain in debt for a 
considerable time after the illness, which created the debt [19]. 
If assets like land and livestock are sold by a poor household, 
they put the household into a vicious circle of poverty [16]. 
Other strategies for dealing with the direct costs of illness 
include diversifying income by engaging in activities other 
than their normal work or selling their labour [18]. In relation 
to coping with the productivity costs of illness, tasks are re-
allocated among household members (intra-household labour 
substitution), in some cases external labour may be hired to 
take on the responsibilities of the ill household members, and 
children may be taken out of school [20]. Intra-household 
labour substitution may have adverse consequences 
particularly when children are removed from school to take on 
the work activities of a sick parent [21].  
In summary, HIV/AIDS is a disease, which has health, 
economic and social consequences.  Thus, it not only affects 
the victim, but also affects the households. Morbidity and 
mortality, income losses (due to direct costs for treatment and 
reduced productivity), and stigma and discrimination are the 
health, economic and social consequences of HIV/AIDS 
respectively. The end impact of all these consequences is 
‘economic’. This means that all these consequences affect the 
income, expenditure and savings of HIV/AIDS affected 
households. These consequences finally push the HIV/AIDS 
affected households into poverty, which can be classified as a 
catastrophic, impoverishing and poverty trap impacts. 
Findings of the previous studies are evident that HIV-affected 
households generate relatively lower household income than 
HIV-unaffected households [22, 23]. HIV-infected people are 
compelled to stop their employment or business due to their 
illness [7]. The burden of treatment is significantly greater in 
HIV-affected households than HIV-unaffected households. 
This burden increases as the PLHA decline in health and that 
produces an even greater impact on the household [6, 23] . The 
households have to spend a higher proportion of their monthly 
income on the care and support of PLHA [24]. The long-term 
treatment for HIV/AIDS can have lifelong financial 
implications on HIV-affected households [25].  
Health insurance is either unavailable for HIV-infected people 
in developing countries [24] or people are not aware of health 
insurance [26]. Therefore, out-of-pocket payment for health 
care is widely used by HIV-affected households in developing 
countries. In case of Nepal, 81.4 % of total health care costs in 
2012 were contributed out-of-pocket from households and the 
rest of the costs (18.6%) were contributed by the government, 
private companies and donors [27]. This also includes the 
health care of HIV/AIDS in Nepal. Moreover, there is no 
social security (e.g. - allowances) in Nepal to the PLHA.  
 
HIV/AIDS in Nepal 
The first case of HIV/AIDS was reported in 1988 in Nepal. 
After that the nature of the HIV epidemic has gradually moved 
from being a ‘low prevalence’ to ‘concentrated epidemic’ [28]. 
In 2014, an estimated 39,249 people were living with 
HIV/AIDS and an estimated 2,576 people died due to the 
disease. An estimated number of 1,493 people were newly 
infected by HIV/AIDS and HIV prevalence rate among adult 
population was 0.02% [29]. However, the total reported HIV 
cases were 25,838 as of December 2014.  According to the 
reported cases, 88 % of people living with HIV/AIDS were 
between the working age of 15-49 years and the majority of 
them were male (63%) [30]. The above evidences suggest that 
HIV/AIDS is a big burden in Nepal because it is concentrated 
on thousands of working age adults.  
Despite considerable efforts from donors, government, non-
governmental organisations (NGOs), and international non-
governmental organisations (INGOs); people living with 
HIV/AIDS have to pay a significant amount of money for their 
treatment and care. PLHA need to pay travel costs, most 
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diagnostic test costs, medicine costs (except ART), lodging 
and food cost. The government provides only Cluster of 
Differentiation 4 (CD4) test services and ART medicines free 
of cost. Wasti et al. reported that PLHA in Nepal faces 
financial constraints for HIV/AIDS treatment. Their report 
states that PLHA are facing difficulty to manage out-of-pocket 
expenses like diagnostic test costs, additional costs incurred 
through travel, nutritional and other user charges [11]. 
Moreover, CD4 count and Facs calibre sites were limited only 
in 28 treatment centres in Nepal, which compelled PLHA to 
travel further for CD4 count tests from time to time. Wasti et 
al. highlighted distance as a major problem because treatment 
centres were concentrated in urban areas or town centres. 
PLHA in the rural hill areas are dying without getting 
treatment because of the lack of travel costs. If the PLHA has 
to go to Kathmandu for CD4 tests, the travel costs are six 
times higher than the average daily income of many Nepalese 
people [11].    
HIV/AIDS is one of the biggest burdens of diseases in Nepal 
as thousands of adults are affected by it. The disease has 
multiple consequences (e.g. - health, economic and social). 
Therefore, it is an important public health issue. However, it 
was assumed that there were only limited numbers of relevant 
studies conducted and no one knows how many published or 
unpublished papers are in Nepal on this issue till date. 
Moreover, there was no review paper published on this topic 
which could be useful to the policy makers at the government 
level and other stakeholders working in the field. Likewise, 
there was no idea among public health researchers about the 
existing knowledge gap on economic burden of HIV/AIDS in 
Nepal.  
This review is conducted to find the existing knowledge gap 
about the economic burden of HIV/AIDS, extent of economic 
burden exerted by the disease at the household level, and to 
provide policy recommendation to the Nepalese Government 
for the welfare of HIV positive people. Therefore, it is 
believed that the results of the review will be helpful to the 
public health researchers, policy makers and other 
stakeholders working in the field of HIV/AIDS in Nepal.  
  
Methodology 
This paper is prepared by reviewing published and 
unpublished literature concerning the economic burden of 
HIV/AIDS in Nepal. Based on the consequences of 
HIV/AIDS, the economic burden was sub-divided into five 
components namely- direct costs, productivity costs, economic 
consequences of stigma and discrimination related to 
HIV/AIDS, coping strategies, and catastrophic and 
impoverishing impacts.  
                             
Figure 2. Flow diagram of the literature selection process for the review study 
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Five different search strategies were used to find the studies 
related to the economic burden of HIV/AIDS. The first search 
strategy used in the study was the direct costs for HIV/AIDS 
in Nepal. The second was studies related to productivity costs 
and the third one dealt with the economic consequences of 
stigma and discrimination. The fourth was the coping 
strategies and the fifth related to the catastrophic and 
impoverishing impacts due to out-of-pocket payment.  
The literature was searched in the Medline (Ovid) search 
engine by using different search words from the records 
ranging from 1990 to Week 2 September 2015. But, the search 
results were limited by full-text and English. However, Google 
(scholar) search and manual search were also carried out to 
find the additional studies for review.   
The major search words used to search the literature were- 
“HIV" or "HIV/AIDS" or "human immunodeficiency virus”; 
“cost$" or "economic burden" or "socioeconomic impact" or 
"economic impact$"; “expenditure" or "health expenditure" or 
"economic consequence$"; "financial impact$" or "financial 
burden" or “productivity loss$" or "productivity cost$" or 
"morbidity"; "work productivity" or "labour productivity" or 
"days lost"; “absenteeism" or "presenteeism" or "disability”; 
“coping strateg$" or "strateg$ to cope" or "coping measure$"; 
“catastrophic" or "catastrophe" or "impoverishment" or 
"impoverishing"; “stigma" or "discrimination"; and “Nepal”. 
While combining all the relevant search words from the 
aforementioned search strategies, a total of 42 studies were 
retrieved from Medline (Ovid); a total of five studies were 
found from Google scholar, and one study was found from 
manual search. After checking the relevancy, a total of seven 
studies were selected for the review.  
The inclusion criteria for the literature were – the research 
which is conducted on HIV/AIDS in Nepal and related to 
direct costs, productivity costs, economic consequences of 
stigma and discrimination, coping strategies (financial), 
catastrophic and impoverishing impacts, the article which full 
text is available, published after 1990 to Week 2 September 
2015, and in English. 
The exclusion criteria for the literature were the research 
articles whose full text were not available, not related to 
Nepal, not related to the household level of economic burden 
(or related to the burden at national level), not related to 
economic consequences of stigma and discrimination, 
published before 1990, and in other languages than English. 
After searching the studies, we synthesised the important 
information from each study about the research methods, 
sample size, study location, and main findings. We contrasted 
and compared these findings based on the similarities, 
differences and represented critically in this paper.  
 
Results 
A total of seven studies were selected based on the criteria set 
above for the review. Among them, three studies were related 
to direct costs of HIV/AIDS treatment [31-33], one of them 
also touched a little about the productivity costs of HIV/AIDS 
[33]. Other four studies were related to the economic 
consequences of stigma and discrimination associated with 
HIV/AIDS [13-15, 34]. However, there was no study which 
investigated the coping strategies, catastrophic and 
impoverishing impacts of HIV/AIDS in Nepal. Details about 
the results and findings of the review are presented below.  
Direct Costs 
While looking at the literatures related to direct costs of 
HIV/AIDS, only three studies were found. Two studies were 
from published articles [31, 32] and one from unpublished 
MSc thesis [33]. Puri et al. and Thapa did cross-sectional 
survey [32, 33], but research method is not clear in the study 
by Pradhan et al. [31]. Puri et al. conducted studies on nine 
cities of Nepal about the costs of sexual and reproductive 
health in 2006 with 1,669 respondents [32]. Thapa conducted 
small survey with 50 respondents who came to take anti-
retroviral medicine (ART) at Teaching Hospital, Kathmandu 
in 2007 [33]. Pradhan et al. calculated costs of care for 
children affected by HIV/AIDS, but their study is silent about 
sample size [31].  
Puri et al. reported the out-of-pocket costs for HIV/AIDS 
treatment for a three month period was only NRs 541 (US$ 
7.5) (NRs 180.3/month) [32]. Thapa found more than double 
the direct costs to visit treatment centre than reported by Puri 
et al.[32, 33]. She found the direct costs of NRs 404 ($7.27) 
per visit to get ART medicine [33]. Considerably lower 
treatment costs in Puri et al.’s study than Thapa’s study may 
be due to two reasons- 38 % of respondents in Puri et al.’s 
study did self-treatment by visiting local pharmacy and they 
included many cities in their study (geographical variations) 
[32, 33].  However, both of the studies did not include costs 
for the accompanying person while visiting the treatment 
centres, only concentrated in the cities and excluded the 
remote rural parts of the country where the HIV positive 
people need to pay up to six times of their daily wage for 
travel costs for their treatment [11]. Moreover, these studies 
did not include diagnostic costs while calculating direct costs 
of treatment [33]. Unlike the above two studies, a study by 
Pradhan et al. reported the actual care costs for HIV-affected 
child per month from societal perspectives- NRs 6,763 (US$ 
93.9), NRs 9,269 (US$ 128.7) and NRs 42,602 (US$ 591.7) in 
community based care, home based care and comprehensive 
institutional care respectively [31]. It should be noted that the 
study by Pradhan et al. is completely different from Puri et al. 
and Thapa because it employs three different models and the 
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costing was done from societal perspectives [31-33]. They did 
not separate costs of HIV/AIDS treatment in their study. 
Therefore, their findings are not directly comparable to the 
other two studies, although they are related.  
The studies reviewed above shows that there are only a limited 
number of studies assessing direct costs of HIV/AIDS 
treatment in Nepal. These studies [32, 33] did not include all 
the costs components for HIV/AIDS treatment and only 
concentrated in the urban areas. Therefore, if the costs 
calculations were done properly, the direct costs for 
HIV/AIDS treatment would have been considerably higher 
than reported in these studies, although the studies reported the 
costs which are big enough to push HIV-affected households 
into poverty.  
Productivity Costs  
There has been no study to measure the productivity costs of 
HIV positive people in Nepal. However, Thapa tried to 
calculate the value of time lost while visiting treatment centres 
to get ART medicine by HIV positive patients in Kathmandu 
valley (NRs 105.2 or US$ 1.5 per visit) [33]. The study did not 
investigate the actual productivity costs of HIV/AIDS in 
Nepal. Here, actual productivity costs mean costs incurred due 
to ill health, which include monetary value of absenteeism and 
presenteeism caused by HIV/AIDS. Therefore, actual 
productivity costs due to HIV/AIDS among HIV positive 
people is still unknown in Nepal.  
Economic Consequences of Stigma and Discrimination 
As there were no proper studies investigating the economic 
consequences of stigma and discrimination related to 
HIV/AIDS in Nepal, all the studies reporting some sorts of 
economic issues are reviewed in this paper.  
There were four studies which touched the economic 
consequences of stigma and discrimination related to 
HIV/AIDS in Nepal. Three of the studies were focussed 
broadly on HIV/AIDS related stigma and discrimination in 
general [13-15] but one study was focussed solely on women’s 
issues related to HIV/AIDS [34]. FHI [34] and FHI [13] 
conducted interviews with 57 respondents in each study but 
Rai conducted mixed methods of interviews (with 7 
respondents) and literature reviews [15]. However, Nepal and 
Ross used secondary data which contained information of 80 
individuals and 12 focus groups discussions [14].  
A study by FHI
 
[13] reported that there was a separation of 
PLHA from communities and families, loss of employment 
and restrictions on movement and activities in communities 
[13]. Moreover, it was reported that HIV positive women were 
discriminated greatly compared to men and more often faced 
permanent loss of family support. FHI [34] also reported 
similar findings. According to FHI [34], HIV positive women 
were not accepted and supported by their family compared to 
their husbands who were also HIV positive. Many women 
faced serious loss of social and economic support from their 
family and society. They also found that deteriorating 
economic conditions with women and their children once their 
husband died [34]. Similar to these findings, Rai reported that 
women face a lack of acceptance and support from family 
members more than their HIV positive husbands. Some 
PLHA, generally women are forced to leave home after the 
detection of HIV status. Moreover, most PLHA face the 
problem of finding work and contributing economically to the 
household [15]. Nepal and Ross also reported that PLHA were 
excluded and rejected from home and society which greatly 
stressed their economic status [14]. Similar to findings 
reported by FHI [13], they also reported that more than 20 % 
of PLHA’s employment was affected negatively after the 
detection of the disease [14].  
The review found that the study findings are very general and 
not quantified in numbers or figures (e.g. – percentage). 
Isolation, rejection, exclusion (from job, family or society), 
less supports were major forms of stigma and discrimination 
which had economic consequences on PLHA. Although all 
PLHA were discriminated, it was found that HIV positive 
women faced more discrimination and less support from their 
family and society, which makes them more vulnerable. There 
is also a need of further study which explores the 
consequences in detail. 
Coping Strategies, Catastrophic and Impoverishing 
Impacts 
The literature review concluded that there were no studies 
relating to the coping strategies (financial) used by HIV/AIDS 
affected households. Likewise, there were no studies reporting 
the catastrophic and impoverishing impacts due to HIV/AIDS 
in Nepal till the date. Therefore, there is a complete knowledge 
gap in these economic issues.  
 
Conclusion 
The review found that there was insufficient research 
concerning economic burden of HIV/AIDS in Nepal. Three of 
the studies assessed the direct costs of HIV/AIDS treatment. 
Nevertheless, these studies did not include all the components 
of the direct costs and did not cover rural and remote areas of 
Nepal. There was no study in Nepal which reported the actual 
productivity costs caused by HIV/AIDS. There were four 
studies which slightly touched the economic consequences of 
stigma and discrimination related to HIV/AIDS in Nepal. 
There were no studies which explored the coping strategies 
used by HIV/AIDS affected households. Likewise, there was 
no study which quantified the catastrophic and impoverishing 
impacts due to HIV/AIDS. Therefore, it is concluded that there 
was no research which assessed the economic burden of 
HIV/AIDS in Nepal covering all the cost components and 
geographical locations. Thus, there is a big knowledge gap 
about the burden in the Nepalese context and we strongly 
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recommend conducting further studies which can explore all 
the issues relating to the economic burden of HIV/AIDS in 
depth covering all geographical locations.  
While looking at the extent of economic burden of HIV/AIDS 
at the household level, it is concluded that the reviewed studies 
under reported the direct costs as they did not include all the 
components (e.g. - diagnostic costs, costs for accompanying 
person) while calculating. They did not calculate the 
productivity costs (value of absenteeism and presentism due to 
HIV/AIDS) too in their studies, which also share big 
proportion of economic burden. Therefore, it was concluded 
that the economic burden exerted by the disease would have 
been very high if they calculated the burden by including all 
the cost items. However, the review findings and available 
evidences suggest that the economic burden of HIV/AIDS is 
big enough to push the HIV-affected households into poverty 
in Nepal.  
We cannot recommend many policies from this review as 
there were limited studies which could not provide sufficient 
knowledge about the economic burden. However, based on the 
available studies and evidences, the review concluded that the 
economic burden of the disease is high at the household level. 
Therefore, the Government of Nepal and other organisations 
working in the field of HIV/AIDS need to focus on reducing 
the economic burden by providing economic supports (e.g. – 
allowances for treatment costs, support for travel costs) to the 
PLHA and increasing awareness level of the general people 
about the HIV/AIDS through trainings and other programmes 
(like radio programme) for reducing stigma and 
discrimination, and thus reducing economic burden on them. 
Moreover, female PLHA need more attention and supports 
than their male counterparts as they were more discriminated 
from their family and society.  
Limitation of the Paper 
This review paper is mainly based on the published studies 
available online (Ovid-Medline and Google scholar) and very 
few unpublished studies (available from manual search). There 
might be other unpublished studies too which we could not 
manage to find manually and did not include in this study. 
This might limit the findings of our study.  
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